Literature DB >> 8151639

Genetic heterogeneity of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in families with familial adenomatous polyposis.

S V Hodgson1, D T Bishop, B Jay.   

Abstract

One hundred and eighteen subjects with familial adenomatous polyposis (FAP) and 80 of their relatives who were at low risk (< 0.01) of carrying the FAP gene were scored by one of us (BJ) or by colleagues to assess the frequency of congenital hypertrophy of the retinal pigment epithelium (CHRPE). A CHRPE is defined as an "oval pigmented lesion surrounded by depigmented halo". Seventy five (63.6%) of the FAP cases and one (1.2%) of their relatives had at least one CHRPE. There was no systematic difference in the number of CHRPEs in the left and right eyes so all analyses are based on total number of CHRPEs and the findings were highly correlated (p = 0.001 for a test of no correlation). There was also no evidence of any age effect in total number of CHRPEs in affected subjects. In 26 families there was more than one subject affected with FAP. There was a significant common family effect with respect to CHRPE expression for total number of CHRPEs with an F statistic of 1.73 (p = 0.02 for a test of no family aggregation) indicating that family members are more similar to each other than to affected subjects from other families. This may indicate that specific mutations play a role in determining the number of CHRPEs. Nine affected subjects had intra-abdominal desmoids, and in these the frequency of each of the types of CHRPE was no higher (in fact, slightly lower) than the average for affected subjects without desmoids, but this difference was not significant (p > 0.3).

Entities:  

Mesh:

Year:  1994        PMID: 8151639      PMCID: PMC1049600          DOI: 10.1136/jmg.31.1.55

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  Histopathological features of congenital fundus lesions in familial adenomatous polyposis.

Authors:  J A Parker; V I Kalnins; J H Deck; Z Cohen; T Berk; J B Cullen; A A Kiskis; W J Ke
Journal:  Can J Ophthalmol       Date:  1990-04       Impact factor: 1.882

2.  Congenital hypertrophy of retinal pigment epithelium: a sign of familial adenomatous polyposis.

Authors:  P D Chapman; W Church; J Burn; A Gunn
Journal:  BMJ       Date:  1989-02-11

3.  Association of congenital hypertrophy of the retinal pigment epithelium with familial adenomatous polyposis.

Authors:  T Iwama; Y Mishima; N Okamoto; J Inoue
Journal:  Br J Surg       Date:  1990-03       Impact factor: 6.939

4.  Pigmented lesions of the retinal pigment epithelium and familial adenomatous polyposis.

Authors:  P J Polkinghorne; S Ritchie; K Neale; G Schoeppner; J P Thomson; B S Jay
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

5.  Hypertrophy of the retinal pigment epithelium associated with Gardner's syndrome.

Authors:  N P Blair; C L Trempe
Journal:  Am J Ophthalmol       Date:  1980-11       Impact factor: 5.258

6.  Familial polyposis coli: the spectrum of ocular and other extracolonic manifestations.

Authors:  M H Heinemann; R H Baker; H H Miller; J J DeCosse
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

7.  A genetic study of Gardner syndrome and congenital hypertrophy of the retinal pigment epithelium.

Authors:  L A Lyons; R A Lewis; L C Strong; S Zuckerbrod; R E Ferrell
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

8.  Hyperpigmented lesions of the retinal pigment epithelium in familial adenomatous polyposis.

Authors:  R H Baker; M H Heinemann; H H Miller; J J DeCosse
Journal:  Am J Med Genet       Date:  1988-10

9.  Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome.

Authors:  E I Traboulsi; A J Krush; E J Gardner; S V Booker; G J Offerhaus; J H Yardley; S R Hamilton; G D Luk; F M Giardiello; S B Welsh
Journal:  N Engl J Med       Date:  1987-03-12       Impact factor: 91.245

10.  Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis.

Authors:  T Berk; Z Cohen; R S McLeod; J A Parker
Journal:  Dis Colon Rectum       Date:  1988-04       Impact factor: 4.585

View more
  5 in total

1.  Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer.

Authors:  Celia S Chen; Kerry D Phillips; Scott Grist; Graeme Bennet; Jamie E Craig; James S Muecke; Graeme K Suthers
Journal:  Fam Cancer       Date:  2006-08-31       Impact factor: 2.375

2.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli.

Authors:  C Soravia; T Berk; L Madlensky; A Mitri; H Cheng; S Gallinger; Z Cohen; B Bapat
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

3.  Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene.

Authors:  D R Davies; J G Armstrong; N Thakker; K Horner; S P Guy; T Clancy; P Sloan; V Blair; C Dodd; T W Warnes
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

4.  Extracolonic features of familial adenomatous polyposis in patients with sporadic colorectal cancer.

Authors:  M G Dunlop; S M Farrington; V J Bubb; C Cunningham; M Wright; L J Curtis; Z A Butt; E Wright; B W Fleck; D Redhead; R Mitchell; J B Rainey; I M Macintyre; D C Carter; A H Wyllie
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

Review 5.  Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations.

Authors:  Louis Antoine Bonnet; R Max Conway; Li-Anne Lim
Journal:  Clin Ophthalmol       Date:  2022-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.